News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Flagship Ventures Fund IV General Partner LLC
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/13/2023 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 1,082,251 shares
@ $2.31, valued at
$2.5M
Bought 3,246,753 shares
@ $2.31, valued at
$7.5M
|
|
| 10/17/2022 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 2,743,902 shares
@ $1.64, valued at
$4.5M
Bought 2,757,333 shares
@ $1.64, valued at
$4.5M
Bought 914,634 shares
@ $1.64, valued at
$1.5M
Bought 919,111 shares
@ $1.64, valued at
$1.5M
Bought 3,048,780 shares
@ $1.64, valued at
$5M
|
|
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/18/2022 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 3,791,623 shares
@ $1.91, valued at
$7.2M
Bought 947,905 shares
@ $1.91, valued at
$1.8M
Bought 1,579,843 shares
@ $1.91, valued at
$3M
|
|
| 03/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/25/2020 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Seres Therapeutics, Inc.|
Txns:
| Disposed of 3,587,820 shares
@ $0
Disposed of 642,180 shares
@ $0
Disposed of 966,234 shares
@ $0
Disposed of 1,186,310 shares
@ $0
Disposed of 1,481,481 shares
@ $0
Disposed of 43,154 shares
@ $0 |
|
| 08/19/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/01/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Bought 666,667 shares
@ $7.5, valued at
$5M
Bought 666,667 shares
@ $7.5, valued at
$5M
Bought 666,666 shares
@ $7.5, valued at
$5M
|
|
| 05/26/2020 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Moderna, Inc.|
Txns:
| Sold 223,314 shares
@ $65.7661, valued at
$14.7M
Sold 121,771 shares
@ $67.1504, valued at
$8.2M
Sold 39,082 shares
@ $68.8144, valued at
$2.7M
Sold 20,492 shares
@ $70.4564, valued at
$1.4M
Sold 13,408 shares
@ $71.5141, valued at
$958.9k
Sold 1,933 shares
@ $72.4351, valued at
$140k
Sold 42,540 shares
@ $65.7661, valued at
$2.8M
Sold 23,199 shares
@ $67.1504, valued at
$1.6M
Sold 7,443 shares
@ $68.8143, valued at
$512.2k
Sold 3,900 shares
@ $70.4564, valued at
$274.8k
Sold 2,551 shares
@ $71.5144, valued at
$182.4k
|
|
| 05/20/2020 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Bought 1,520,000 shares
@ $4.75, valued at
$7.2M
Bought 380,000 shares
@ $4.75, valued at
$1.8M
Bought 1,900,000 shares
@ $4.75, valued at
$9M
|
|
| 05/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2019 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Moderna, Inc.|
Txns:
| Disposed of 6,292,342 shares
@ $0
Disposed of 1,207,658 shares
@ $0
Disposed of 1,735,720 shares
@ $0
Sold 144,423 shares
@ $18.9942, valued at
$2.7M
Sold 27,714 shares
@ $18.9943, valued at
$526.4k
Sold 21,325 shares
@ $18.9586, valued at
$404.3k
Sold 4,092 shares
@ $18.9586, valued at
$77.6k
Sold 199,935 shares
@ $18.6548, valued at
$3.7M
Sold 38,366 shares
@ $18.6548, valued at
$715.7k
|
|
| 10/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/15/2019 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Axcella Health Inc.|
Txns:
| Converted 751,691 shares
@ $0
Converted 2,255,074 shares
@ $0
Converted 209,933 shares
@ $0
Converted 503,840 shares
@ $0
Converted 545,826 shares
@ $0
Converted 120,795 shares
@ $0
Converted 335,457 shares
@ $0
Converted 82,324 shares
@ $0
Converted 194,409 shares
@ $0
Converted 48,602 shares
@ $0
Converted 486,023 shares
@ $0 |
|
| 05/06/2019 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on TransMedics Group, Inc.|
Txns:
| Disposed of 750,000 shares
@ $0
Acquired 214,285 shares
@ $0
Disposed of 940,579 shares
@ $0
Acquired 268,736 shares
@ $0
Converted 1,254,888 shares
@ $0
Converted 792,366 shares
@ $0
Converted 2,000,000 convertible preferred
@ $0
Converted 1,400,000 convertible preferred
@ $0
Converted 992,110 convertible preferred
@ $0
Converted 1,257,465 convertible preferred
@ $0
Converted 600,000 convertible preferred
@ $0 |
|
| 03/06/2019 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Kaleido Biosciences, Inc.|
Txns:
| Converted 665,908 shares
@ $0
Converted 173,586 shares
@ $0
Converted 281,203 shares
@ $0
Converted 1,331,816 preferred shares
@ $0
Converted 347,173 preferred shares
@ $0
Converted 562,407 preferred shares
@ $0 |
|
| 12/13/2018 |
4
| AFEYAN NOUBAR (10% Owner) has filed a Form 4 on Moderna, Inc.|
Txns:
| Converted 7,292,145 shares
@ $0
Converted 1,823,036 shares
@ $0
Converted 24,782,551 shares
@ $0
Converted 6,195,632 shares
@ $0
Converted 5,713,739 shares
@ $0
Converted 1,428,432 shares
@ $0
Converted 85,989 shares
@ $0
Converted 21,496 shares
@ $0
Converted 7,292,145 preferred shares
@ $0
Converted 1,823,036 preferred shares
@ $0
Converted 24,782,551 preferred shares
@ $0 |
|
| 07/23/2018 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Rubius Therapeutics, Inc.|
Txns:
| Converted 15,323,593 shares
@ $0
Converted 3,830,402 shares
@ $0
Converted 5,000,000 shares
@ $0
Converted 5,000,000 shares
@ $0
Converted 593,948 shares
@ $0
Converted 593,948 shares
@ $0
Converted 1,781,843 shares
@ $0
Converted 195,466 shares
@ $0
Converted 195,466 shares
@ $0
Converted 781,860 shares
@ $0
Converted 15,323,593 preferred shares
@ $0 |
|
| 05/15/2018 |
4
| Flagship Ventures Fund IV General Partner LLC (10% Owner) has filed a Form 4 on Evelo Biosciences, Inc.|
Txns:
| Converted 14,622,143 shares
@ $0
Bought 281,250 shares
@ $16, valued at
$4.5M
Converted 12,536,945 preferred shares
@ $0
Converted 10,102,055 preferred shares
@ $0
Converted 5,416,667 preferred shares
@ $0
Converted 8,333,000 options to buy
@ $0
Converted 18,611,110 preferred shares
@ $0
Converted 4,643,963 preferred shares
@ $0 |
|
| 08/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/26/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/21/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/08/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/15/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/07/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/27/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|